|
| Status |
Public on May 01, 2020 |
| Title |
Reducing metastases stiffness by targeting fibroblasts improves therapeutic outcome in colorectal cancer [Cells] |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
Analysis of primary fibroblasts isolated from human colorectal primary tumors(CAFs) and liver metastases(MAFs) and identify corresponding gene expression signatures
|
| |
|
| Overall design |
6 CAFs and 6 MAFs cell samples deriving from 12 patients are examined with Next Generation Sequencing (NGS)
|
| |
|
| Contributor(s) |
Schmidt T, Shen Y |
| Citation(s) |
32516590 |
| |
| Submission date |
Feb 18, 2020 |
| Last update date |
Jul 31, 2020 |
| Contact name |
Thomas Schmidt |
| E-mail(s) |
thomas.schmidt1@med.uni-heidelberg.de
|
| Organization name |
University Hospital Heidelberg
|
| Department |
Department of General, Visceral and Transplantation Surgery
|
| Street address |
Im Neuenheimer Feld 110
|
| City |
Heidelberg |
| State/province |
Baden-Württemberg |
| ZIP/Postal code |
69117 |
| Country |
Germany |
| |
|
| Platforms (1) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
| Samples (12)
|
|
| This SubSeries is part of SuperSeries: |
| GSE145432 |
Reducing metastases stiffness by targeting fibroblasts improves therapeutic outcome in colorectal cancer |
|
| Relations |
| BioProject |
PRJNA607211 |
| SRA |
SRP249793 |
Less...
More...